| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 03/16/2006 | WO2006027070A1 Method for the production of heterocyclic quaternary ammonium compounds and/or guanidine compounds having high purity |
| 03/16/2006 | WO2005034850A3 Cycloalkyl heterocycles for treating hepatitis c virus |
| 03/16/2006 | US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 03/16/2006 | US20060058298 Inhibitors of histone deacetylase |
| 03/16/2006 | US20060058289 Mercaptoimidazoles as ccr2 receptor antagonists |
| 03/16/2006 | DE102004043826A1 Mixture of two metal azo complexes useful as a light absorber in the information layer of a write-once optical data carrier |
| 03/16/2006 | CA2579886A1 Novel imidazolidine derivative and use thereof |
| 03/16/2006 | CA2577634A1 Synthesis of triethylenetetramines |
| 03/15/2006 | EP1634874A1 Imidazolidine derivative |
| 03/15/2006 | EP1634867A1 Tricyanomethane salts of organic cations |
| 03/15/2006 | EP1633310A2 Thiotungstate analogues and uses thereof |
| 03/15/2006 | EP1227085B1 Process for producing optically active naphthalene derivative and optical resolver therefor |
| 03/15/2006 | EP0997147B1 Amino acid derivatives |
| 03/15/2006 | CN1747936A Substituted azole derivatives as therapeutic agents |
| 03/15/2006 | CN1245381C Phenylglycine derivatives |
| 03/14/2006 | US7012152 Reduction of 2-amino-6-methyl-6-nitroheptanoic acid |
| 03/14/2006 | US7012075 Cathepsin cysteine protease inhibitors |
| 03/14/2006 | CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 03/14/2006 | CA2234491C Preparation of bioactive compounds by plasma synthesis |
| 03/14/2006 | CA2176557C Phenyl-alkyl imidazoles as h3-receptor antagonists |
| 03/14/2006 | CA2103838C Novel 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 03/09/2006 | WO2006025598A1 Suppressant for cerebral infarction attributed to long-time ischemia |
| 03/09/2006 | WO2006025482A1 Proton conductor and fuel cell using the same |
| 03/09/2006 | WO2006024779A1 Sulphonamide derivatives, their preparation and their therapeutic application |
| 03/09/2006 | WO2006004924A3 Imidazolo-related compounds, compositions and methods for their use |
| 03/09/2006 | WO2005105770A3 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives |
| 03/09/2006 | WO2005097755A3 Imidazol derivatives as tyrosine kinase inhibitors |
| 03/09/2006 | WO2005091697A3 Thiourea compositions and uses thereof |
| 03/09/2006 | US20060052445 Diarylsulfones as 5-HT2A antagonists |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052388 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 03/09/2006 | US20060052358 Modulators of ATP-binding cassette transporters |
| 03/09/2006 | US20060051846 Process for producing l-alpha-methylcysteine derivative |
| 03/09/2006 | DE102004043632A1 Verfahren zur Herstellung heterocyclischer quartärer Ammonium- und/oder Guanidinium-Verbindungen A process for the preparation of heterocyclic quaternary ammonium and / or guanidinium compounds |
| 03/09/2006 | DE102004043631A1 Verfahren zur Herstellung heterocyclischer quartärer Ammonium- Verbindungen und/oder Guanidinium- Verbindungen hoher Reinheit Process for the preparation of heterocyclic quaternary ammonium compounds and / or guanidinium compounds of high purity |
| 03/09/2006 | CA2577220A1 Sulphonamide derivatives, their preparation and their therapeutic application |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1631552A2 Method for synthesising heterocyclic compounds from thiourea derivates |
| 03/08/2006 | EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 03/08/2006 | EP1631260A2 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1453838B1 Production of ionic liquids |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1198454B1 Mutilin derivatives and their use as antibacterials |
| 03/08/2006 | CN1745069A Mercaptoimidazoles as CCR2 receptor antagonists |
| 03/08/2006 | CN1743317A Method for preparing amino formyl imidazole |
| 03/08/2006 | CN1743316A 2-substituted phenyl-4,4,5,5-tetramethyl-1,3,-dioxy imidazolines, their preparation and pharmaceutical use |
| 03/08/2006 | CN1743315A 2-substituted-4,4,5,5-tetramethyl-1-hydroxyimidazoline, and its synthesis and use |
| 03/08/2006 | CN1743314A 2-substituted-4,4,5,5-tetramethyl-1-oxyimidazoline, and its synthesis and use |
| 03/07/2006 | US7008636 such as 5'-Octadecyloxy-[1,1';3',1'']terphenyl-2'-yloxy acetic acid for inhibiting Protien-Tyrosine Phosphatases(PTPases) from rat liver microsomes in vitro; for treatment of associated obesity, glucose intolerance, diabetes mellitus, hypertension |
| 03/02/2006 | WO2006023167A2 Process for producing n-halogenated organic compounds |
| 03/02/2006 | WO2006021806A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
| 03/02/2006 | WO2006021805A1 Diarylsulfones as 5-ht2a antagonists |
| 03/02/2006 | WO2006021390A1 Method for the production of tricyanomethanides of organic cations |
| 03/02/2006 | WO2006021302A1 Method for producing high-purity quaternary ammonium compounds |
| 03/02/2006 | WO2005092305A3 Compounds for treating aids and other diseases |
| 03/02/2006 | WO2005085207A3 Method for the production of ionic fluids the cation of which comprises a quaternary sp2 - hybridised nitrogen atom |
| 03/02/2006 | WO2005072132A3 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
| 03/02/2006 | WO2004110364A3 Thiotungstate analogues and uses thereof |
| 03/02/2006 | US20060047116 Such as N-methyl(1-{2-[(1R,5S)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-2,3-dihydro-1H-inden-1-yl)methanamine; chemokine receptor antagonists; prevention or treatment of a human T-cell leukemia/lymphoma virus infection |
| 03/02/2006 | CA2577837A1 Diarylsulfones as 5-ht2a antagonists |
| 03/01/2006 | CN1742044A Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 03/01/2006 | CN1740163A Type-Y second order non-linear optical chromophore containing imidazolyl heterocycle and its synthesis process |
| 03/01/2006 | CN1243738C Method for preparing 1-proparagyl hydantoin |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 03/01/2006 | CN1243567C Growth hormone secretagogues |
| 02/28/2006 | US7005436 Heterocyclo inhibitors of potassium channel function |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005087 Composition and method for preventing fouling in (meth)acrylic acid processes |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/23/2006 | WO2005110980A3 Aryl sulfones and uses related thereto |
| 02/23/2006 | US20060041114 Activators for oligonucleotide synthesis |
| 02/23/2006 | US20060041001 Useful in the treatment of diseases or conditions susceptible to adrenergic regulation controlled by alpha-2 adrenergic receptors |
| 02/23/2006 | US20060040973 Novel guanidine mimics as factor Xa inhibitors |
| 02/23/2006 | DE102004040016A1 Preparation of ionic liquids, useful as electrolytes, comprises reacting anion compounds with heterocyclic compounds and phosphor containing compounds, reacting the resulting product with e.g. ether and continuously isolating the product |
| 02/23/2006 | DE102004039281A1 UV Filter UV filter |
| 02/23/2006 | CA2576388A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 02/22/2006 | EP1626962A1 Benzamide inhibitors of the p2x7 receptor |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | CN1738806A Oxo-azabicyclic compounds |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/22/2006 | CN1243001C Method of manufacturing sertindole |
| 02/21/2006 | US7002036 For production of (poly)peptides; comprises Michael-type addition of nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and conversion of ester to amino moiety |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7001926 Tubulin binding agents and corresponding prodrug constructs |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/21/2006 | US7001605 Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same |
| 02/21/2006 | US7001436 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye |
| 02/21/2006 | CA2184691C L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
| 02/16/2006 | WO2006016598A1 Biological low-molecular weight derivative, crosslinked matter and biodegradable and absorbable adhesive material for medical use |
| 02/16/2006 | WO2006016218A1 Aryl or heteroaryl carbonyl derivatives derivatives useful as vanilloid receptor 1 (vr1) antagonists |
| 02/16/2006 | WO2006016152A1 Anti-inflammatory agents |
| 02/16/2006 | WO2006015986A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/16/2006 | US20060036099 Bromination or chlorination of hydantoin |
| 02/16/2006 | US20060035899 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein |
| 02/16/2006 | US20060035137 Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery |
| 02/16/2006 | DE102004035322A1 Selektive Hemmstoffe humaner Corticoidsynthasen Selective inhibitors of human Corticoidsynthasen |
| 02/16/2006 | DE102004034543A1 Verfahren zur Herstellung von Onium-Salzen mit geringem Chlorid-Gehalt A process for the preparation of onium salts having a low chloride content |
| 02/16/2006 | CA2576257A1 Anti-inflammatory agents |
| 02/16/2006 | CA2573066A1 Mercaptoimidazoles as ccr2 receptor antagonists |